SCHEMBL6163724

SCHEMBL6163724

CCCc1nn(-c2ccccc2)c2c1C(=O)CC(C)(C)C2

nearest known ligand 0.65

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
NPSR1 Q6W5P4 2/20 0.65
KMT2A Q03164 1/20 0.65
LMNA P02545 3/20 0.58
ALPL P05186 2/20 0.57
OPRM1 P35372 10/20 0.52
GAA P10253 1/20 0.51
HSP90AB1 P08238 1/20 0.49
TSHR P16473 1/20 0.47
SRC P12931 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6767582 0.88 ALDH1A1 (0.56) ALDH1A1NPSR1KMT2ALMNAALPL
SCHEMBL6772480 0.87 ALDH1A1 (0.67) ALDH1A1NPSR1KMT2ALMNAALPL
SCHEMBL6772068 0.86 ALDH1A1 (0.57) ALDH1A1NPSR1KMT2ALMNAALPL
SCHEMBL6770581 0.85 ALDH1A1 (0.62) ALDH1A1NPSR1KMT2ALMNAALPL
SCHEMBL6162256 0.84 OPRM1 (0.50) ALDH1A1NPSR1KMT2ALMNAOPRM1
SCHEMBL6167358 0.83 ALDH1A1 (0.57) ALDH1A1NPSR1KMT2ALMNAALPL
SCHEMBL6166305 0.80 OPRM1 (0.76) ALDH1A1KMT2ALMNAOPRM1TSHR
SCHEMBL6162867 0.80 ALDH1A1 (0.49) ALDH1A1NPSR1KMT2ALMNAOPRM1
SCHEMBL6164280 0.78 OPRM1 (0.45) ALDH1A1NPSR1KMT2ALMNAOPRM1
SCHEMBL6165095 0.78 ALDH1A1 (0.58) ALDH1A1NPSR1KMT2ALMNAALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed